Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
06 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/06/3074989/0/en/Actuate-Therapeutics-Announces-Statistically-Significant-Topline-Results-from-Global-Phase-2-Trial-of-Elraglusib-in-First-Line-Treatment-of-Metastatic-Pancreatic-Cancer.html
30 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/30/3071302/0/en/Actuate-Therapeutics-to-Participate-in-Citizens-Life-Sciences-Conference-2025.html
23 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/23/3066581/0/en/Actuate-to-Present-Elraglusib-Phase-2-Topline-Data-at-the-2025-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting.html
17 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/17/3063291/0/en/Actuate-to-Present-Promising-Data-on-Elraglusib-in-Advanced-Salivary-Gland-Carcinoma-at-the-AACR-Annual-Meeting-2025.html
25 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/25/3031941/0/en/Actuate-Announces-Completion-of-Enrollment-in-a-Phase-2-Trial-of-Elraglusib-in-Combination-with-FOLFIRINOX-and-Losartan-in-Patients-with-Previously-Untreated-Metastatic-Pancreatic-.html
06 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/06/3021974/0/en/Actuate-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences-in-February.html
ABOUT THIS PAGE